Adrenocorticosteroids and adrenocortical antagonists

The information contained on this site is general in nature and is intended for use as an informational aid. It does not cover all possible uses, actions, precautions, side effects, or interactions of the medications shown, nor is the information intended as medical advice or diagnosis for individual health problems or for making an evaluation as to the risks and benefits of using a particular medication. You should consult your doctor about diagnosis and treatment of any health problems. Information and statements have not been evaluated by the Food and Drug Administration ("FDA"), nor has the FDA approved the medications to diagnose, cure or prevent disease.

In patients with severely impaired renal function or decreased urate clearance, the half-life of oxypurinol in the plasma is greatly prolonged. Patients should be treated with the lowest effective dose, in order to minimize possible side effects. The appropriate dose of allopurinol sodium for injection for patients with a creatinine clearance ≤10 mL/min is 100 mg per day. For patients with a creatinine clearance between 10 and 20 mL/min, a dose of 200 mg per day is recommended. With extreme renal impairment (creatinine clearance less than 3 mL/min), the interval between doses may also need to be extended.

Adrenocorticosteroids and adrenocortical antagonists

adrenocorticosteroids and adrenocortical antagonists

Media:

adrenocorticosteroids and adrenocortical antagonistsadrenocorticosteroids and adrenocortical antagonistsadrenocorticosteroids and adrenocortical antagonistsadrenocorticosteroids and adrenocortical antagonistsadrenocorticosteroids and adrenocortical antagonists